John Henderson
Chairman at CYTOKINETICS, INCORPORATED
Net worth: 2 M $ as of 31/03/2024
Profile
Dr. John T.
Henderson, MD, is a Chairman at Cytokinetics, Inc. Dr. Henderson was previously employed as an Independent Director by Myrexis, Inc., an Independent Director by Myriad Genetics, Inc., a President by Futurepharm LLC, a Chairman by Asmacure Ltée, a Non-Executive Director by Inveresk Research Group, Inc., a Chief Development Officer by NeuroVia, Inc., a VP-Europe, US & International Pharmaceuticals by Pfizer Inc., and a Vice President by Pfizer Pharmaceuticals, Inc. He received his undergraduate degree from The University of Edinburgh and a doctorate degree from The University of Edinburgh.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
25/04/2024 | 32,153 ( 0.03% ) | 2 M $ | 31/03/2024 |
John Henderson active positions
Companies | Position | Start |
---|---|---|
CYTOKINETICS, INCORPORATED | Chairman | 08/04/2022 |
Former positions of John Henderson
Companies | Position | End |
---|---|---|
MYRIAD GENETICS, INC. | Chairman | 23/03/2020 |
NeuroVia, Inc.
NeuroVia, Inc. Pharmaceuticals: MajorHealth Technology Neurovia, Inc. provides small molecule therapeutics for the treatment of neurologic disorders. The company was founded by Thomas Scanlan in 2014 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/10/2018 |
MYREXIS, INC. | Director/Board Member | 01/01/2013 |
PFIZER, INC. | Corporate Officer/Principal | 01/12/2010 |
Pfizer Pharmaceuticals, Inc.
Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Pharmaceuticals, Inc. is an American company that manufactures pharmaceutical products. | Corporate Officer/Principal | 01/12/2000 |
Training of John Henderson
The University of Edinburgh | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
PFIZER, INC. | Health Technology |
MYRIAD GENETICS, INC. | Health Technology |
CYTOKINETICS, INCORPORATED | Health Technology |
MYREXIS, INC. | Finance |
Private companies | 5 |
---|---|
Inveresk Research Group, Inc.
Inveresk Research Group, Inc. Miscellaneous Commercial ServicesCommercial Services Inveresk Research Group, Inc. provides drug development services to companies in the pharmaceutical and biotechnology industries. The company offers pre-clinical safety & pharmacology evaluation, laboratory sciences, and clinical development services. Inveresk Research Group was founded in 1999 and is headquartered in Cary, NC. | Commercial Services |
Asmacure Ltée
Asmacure Ltée Pharmaceuticals: MajorHealth Technology Asmacure Ltée develops novel, proprietary compounds that target cholinergic receptors for the treatment of inflammation, notably pulmonary airway diseases. The company was founded by Yvon Cormier and Evelyne Israel-Assayag in 2002 and is headquartered in Quebec, Canada. | Health Technology |
Pfizer Pharmaceuticals, Inc.
Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Pharmaceuticals, Inc. is an American company that manufactures pharmaceutical products. | Health Technology |
Futurepharm LLC | |
NeuroVia, Inc.
NeuroVia, Inc. Pharmaceuticals: MajorHealth Technology Neurovia, Inc. provides small molecule therapeutics for the treatment of neurologic disorders. The company was founded by Thomas Scanlan in 2014 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- John Henderson